| Adriana Katherine Albors, MS, PLMFT | |
|
3216 Gillham Plz Ste 210, Kansas City, MO 64109-1742 | |
| (816) 226-6433 | |
| Not Available |
| Full Name | Adriana Katherine Albors |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 3216 Gillham Plz Ste 210, Kansas City, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891414827 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | 2021049031 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Adriana Katherine Albors, MS, PLMFT 3216 Gillham Plz Ste 210, Kansas City, MO 64109-1742 Ph: (816) 226-6433 | Adriana Katherine Albors, MS, PLMFT 3216 Gillham Plz Ste 210, Kansas City, MO 64109-1742 Ph: (816) 226-6433 |
News Archive
Although researchers have been seeking the origins of preterm birth for many years, the causes are still relatively unknown. By studying the electrical activity that causes contractions, researchers at Washington University in St. Louis and their collaborators have developed a multiscale model they believe may aid in predicting preterm birth.
Surgical Information Systems ('SIS') today announced a partnership with Siemens Healthcare expanding the reach of the Siemens health information system portfolio (including Soarian®, INVISION® and MedSeries4®) into the perioperative environment, including the SIS Anesthesia solution.
The heyday for nanotech venture capital (VC) likely saw its peak in 2008, when overall investment reached $1.4 billion. Last year, the sector raised only $792 million, signifying a 42% decline from 2008. But while overall nano VC backing is down, it's not out, according to a new report from Lux Research.
Ceragenix Pharmaceuticals, Inc. ("Ceragenix") (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology, today announced that the National Institutes of Health ("NIH") has awarded a $2.87 million grant to fund the pre clinical development of a Ceragenin™based oral drug to treat two common and potentially deadly gastrointestinal infections: Clostrdium difficile and Shigella.
A research team led by St. Jude Children's Research Hospital immunologists has discovered how a set of proteins delays the "executioner" machinery that kills damaged or infected cells in a process called necroptosis.
› Verified 1 days ago
Katie Ballard, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 3743 Main St, Kansas City, MO 64111 Phone: 816-806-7107 | |
Jerome Alexander Hawkins, S-MFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 3601 Main St, Kansas City, MO 64111 Phone: 816-729-5533 | |
Halee Winfrey, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 118 Southwest Blvd Ste 300, Kansas City, MO 64108 Phone: 816-226-7366 | |
Amanda L Rexwinkle, LCMFT, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 5736 N Broadway St, Kansas City, MO 64118 Phone: 816-866-6053 | |
Mr. Jeffery M Sumler, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 7611 State Line Rd, Ste. 142, Kansas City, MO 64114 Phone: 816-763-7605 Fax: 816-763-1802 | |
Mrs. Shara Adrianne Mcglothan, PLMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 107 W 9th St Unit 322, Kansas City, MO 64105 Phone: 816-974-7025 | |
Martha Jolene Boyd, M.S., LPC Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 620 E 18th St, Kansas City, MO 64108 Phone: 816-445-4285 |